Macular oedema can lead to severe visual loss especially if the the centre of the macula; the fovea is involved. Intravitreal therapies are becoming increasingly popular in the treatment of centre involving diabetic macular oedema (CIDMO).
The aim of the audit was to assess the prevalence of CIDMO in the local population and to determine the risk factors for CIDMO.
